retatrutide phase 3 results Eli Lilly Announces Positive for | Ahmad Bahareth, MD posted on the topic Retatrutide Phase 3 Trial RESULTS

This raises a fundamental ethical question: For how long can it be ethically justifiedand not considered a form of misconductto withhold or fail to actively offer an evidence-based, disease-modifying therapy, when patients subsequently suffer preventable consequences such as reduced health span, premature mortality, sudden cardiac death, cancer or progressive complications of diabetes and other obesity-related diseases

The good news for most members is that the side effect window is front-loaded

PT-141: nausea, flushing, mild headache

Pharmacogenomics, a field that examines how genetics affect drug responses, offers a cost-effective solution to the trial-and-error approach of prescribing